APO Research
Talk to an analyst

APO RESEARCH · REPORT

Megestrol

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Megestrol Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchMegestrol Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Megestrol Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Megestrol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Megestrol Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Megestrol Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Megestrol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Megestrol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Megestrol market include Abbott, Takeda, Sandoz, Novartis, Mylan, Pfizer, GSK, Mayne Pharma and Guccess, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Megestrol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Megestrol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Megestrol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Megestrol market size, projected growth trends, production technologies, key applications, and end-use industries.

Megestrol Segment by Company

Abbott

Takeda

Sandoz

Novartis

Mylan

Pfizer

GSK

Mayne Pharma

Guccess

Bristol Myers Squibb

Abnova

Megestrol Segment by Type

Oral Suspension

Tablet

Injection

Others

Megestrol Segment by Application

Hospital

Clinic

Others

Megestrol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Megestrol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Megestrol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Megestrol significant trends, drivers, influence factors in global and regions.

6. To analyze Megestrol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Megestrol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Megestrol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Megestrol industry.

Chapter 3: Detailed analysis of Megestrol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Megestrol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Megestrol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Megestrol Industry Trends Table 2. Megestrol Industry Drivers Table 3. Megestrol Industry Opportunities and Challenges Table 4. Megestrol Industry Restraints Table 5. Global Megestrol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Megestrol Revenue Share by Company (2021-2026) Table 7. Global Megestrol Sales Volume by Company (k units) & (2021-2026) Table 8. Global Megestrol Sales Volume Share by Company (2021-2026) Table 9. Global Megestrol Average Price (US$/unit) of Company (2021-2026) Table 10. Global Megestrol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Megestrol Key Company Manufacturing Base & Headquarters Table 12. Global Megestrol Company, Product Type & Application Table 13. Global Megestrol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Megestrol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Suspension Table 18. Significant Companies of Tablet Table 19. Significant Companies of Injection Table 20. Significant Companies of Others Table 21. Global Megestrol Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Megestrol Sales Volume by Type (2021-2026) & (k units) Table 23. Global Megestrol Sales Volume by Type (2027-2032) & (k units) Table 24. Global Megestrol Sales Volume Share by Type (2021-2026) Table 25. Global Megestrol Sales Volume Share by Type (2027-2032) Table 26. Global Megestrol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Megestrol Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Megestrol Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Megestrol Sales Value Share by Type (2021-2026) Table 30. Global Megestrol Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Megestrol Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Megestrol Sales Volume by Application (2021-2026) & (k units) Table 36. Global Megestrol Sales Volume by Application (2027-2032) & (k units) Table 37. Global Megestrol Sales Volume Share by Application (2021-2026) Table 38. Global Megestrol Sales Volume Share by Application (2027-2032) Table 39. Global Megestrol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Megestrol Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Megestrol Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Megestrol Sales Value Share by Application (2021-2026) Table 43. Global Megestrol Sales Value Share by Application (2027-2032) Table 44. Global Megestrol Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Megestrol Sales by Region (2021-2026) & (k units) Table 46. Global Megestrol Sales Market Share by Region (2021-2026) Table 47. Global Megestrol Sales by Region (2027-2032) & (k units) Table 48. Global Megestrol Sales Market Share by Region (2027-2032) Table 49. Global Megestrol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Megestrol Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Megestrol Sales Value Share by Region (2021-2026) Table 52. Global Megestrol Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Megestrol Sales Value Share by Region (2027-2032) Table 54. Global Megestrol Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Megestrol Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Megestrol Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Megestrol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Megestrol Sales by Country (2021-2026) & (k units) Table 59. Global Megestrol Sales Market Share by Country (2021-2026) Table 60. Global Megestrol Sales by Country (2027-2032) & (k units) Table 61. Global Megestrol Sales Market Share by Country (2027-2032) Table 62. Global Megestrol Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Megestrol Sales Value Market Share by Country (2021-2026) Table 64. Global Megestrol Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Megestrol Sales Value Market Share by Country (2027-2032) Table 66. Abbott Company Information Table 67. Abbott Business Overview Table 68. Abbott Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Abbott Megestrol Product Portfolio Table 70. Abbott Recent Development Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Megestrol Product Portfolio Table 75. Takeda Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sandoz Megestrol Product Portfolio Table 80. Sandoz Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Novartis Megestrol Product Portfolio Table 85. Novartis Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Mylan Megestrol Product Portfolio Table 90. Mylan Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Megestrol Product Portfolio Table 95. Pfizer Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GSK Megestrol Product Portfolio Table 100. GSK Recent Development Table 101. Mayne Pharma Company Information Table 102. Mayne Pharma Business Overview Table 103. Mayne Pharma Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Mayne Pharma Megestrol Product Portfolio Table 105. Mayne Pharma Recent Development Table 106. Guccess Company Information Table 107. Guccess Business Overview Table 108. Guccess Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Guccess Megestrol Product Portfolio Table 110. Guccess Recent Development Table 111. Bristol Myers Squibb Company Information Table 112. Bristol Myers Squibb Business Overview Table 113. Bristol Myers Squibb Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Bristol Myers Squibb Megestrol Product Portfolio Table 115. Bristol Myers Squibb Recent Development Table 116. Abnova Company Information Table 117. Abnova Business Overview Table 118. Abnova Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Abnova Megestrol Product Portfolio Table 120. Abnova Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Megestrol Distributors List Table 124. Megestrol Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Megestrol Product Image Figure 2. Global Megestrol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Megestrol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Megestrol Sales (2021-2032) & (k units) Figure 5. Global Megestrol Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Megestrol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Suspension Image Figure 10. Tablet Image Figure 11. Injection Image Figure 12. Others Image Figure 13. Global Megestrol Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Megestrol Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Megestrol Sales Volume Share by Type (2021-2032) Figure 16. Global Megestrol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Megestrol Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Megestrol Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Megestrol Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Megestrol Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Megestrol Sales Volume Share by Application (2021-2032) Figure 25. Global Megestrol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Megestrol Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Megestrol Sales Value Share by Application (2021-2032) Figure 28. Global Megestrol Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Megestrol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Megestrol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Megestrol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Megestrol Sales Value (2021-2032) & (US$ Million) Figure 33. North America Megestrol Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Megestrol Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Megestrol Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Megestrol Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Megestrol Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Megestrol Sales Value (2021-2032) & (US$ Million) Figure 39. South America Megestrol Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Megestrol Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Megestrol Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Megestrol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Megestrol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Megestrol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Megestrol Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Megestrol Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Suspension
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Takeda
  • Sandoz
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Mayne Pharma
  • Guccess
  • Bristol Myers Squibb
  • Abnova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Megestrol Sales Value (2021-2032)
  4. 1.2.2 Global Megestrol Sales Volume (2021-2032)
  5. 1.2.3 Global Megestrol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Megestrol Market Dynamics
  1. 2.1 Megestrol Industry Trends
  2. 2.2 Megestrol Industry Drivers
  3. 2.3 Megestrol Industry Opportunities and Challenges
  4. 2.4 Megestrol Industry Restraints
3 Megestrol Market by Company
  1. 3.1 Global Megestrol Company Revenue Ranking in 2025
  2. 3.2 Global Megestrol Revenue by Company (2021-2026)
  3. 3.3 Global Megestrol Sales Volume by Company (2021-2026)
  4. 3.4 Global Megestrol Average Price by Company (2021-2026)
  5. 3.5 Global Megestrol Company Ranking (2024-2026)
  6. 3.6 Global Megestrol Company Manufacturing Base and Headquarters
  7. 3.7 Global Megestrol Company Product Type and Application
  8. 3.8 Global Megestrol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Megestrol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Megestrol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Megestrol Market by Type
  1. 4.1 Megestrol Type Introduction
  2. 4.1.1 Oral Suspension
  3. 4.1.2 Tablet
  4. 4.1.3 Injection
  5. 4.1.4 Others
  6. 4.2 Global Megestrol Sales Volume by Type
  7. 4.2.1 Global Megestrol Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Megestrol Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Megestrol Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Megestrol Sales Value by Type
  11. 4.3.1 Global Megestrol Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Megestrol Sales Value by Type (2021-2032)
  13. 4.3.3 Global Megestrol Sales Value Share by Type (2021-2032)
5 Megestrol Market by Application
  1. 5.1 Megestrol Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Megestrol Sales Volume by Application
  6. 5.2.1 Global Megestrol Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Megestrol Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Megestrol Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Megestrol Sales Value by Application
  10. 5.3.1 Global Megestrol Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Megestrol Sales Value by Application (2021-2032)
  12. 5.3.3 Global Megestrol Sales Value Share by Application (2021-2032)
6 Megestrol Regional Sales and Value Analysis
  1. 6.1 Global Megestrol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Megestrol Sales by Region (2021-2032)
  3. 6.2.1 Global Megestrol Sales by Region: 2021-2026
  4. 6.2.2 Global Megestrol Sales by Region (2027-2032)
  5. 6.3 Global Megestrol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Megestrol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Megestrol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Megestrol Sales Value by Region (2027-2032)
  9. 6.5 Global Megestrol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Megestrol Sales Value (2021-2032)
  12. 6.6.2 North America Megestrol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Megestrol Sales Value (2021-2032)
  15. 6.7.2 Europe Megestrol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Megestrol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Megestrol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Megestrol Sales Value (2021-2032)
  21. 6.9.2 South America Megestrol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Megestrol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Megestrol Sales Value Share by Country, 2025 VS 2032
7 Megestrol Country-level Sales and Value Analysis
  1. 7.1 Global Megestrol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Megestrol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Megestrol Sales by Country (2021-2032)
  4. 7.3.1 Global Megestrol Sales by Country (2021-2026)
  5. 7.3.2 Global Megestrol Sales by Country (2027-2032)
  6. 7.4 Global Megestrol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Megestrol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Megestrol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Megestrol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Megestrol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Megestrol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Megestrol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Megestrol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Megestrol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Megestrol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Megestrol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Megestrol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Megestrol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Megestrol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Megestrol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Megestrol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Megestrol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Megestrol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Megestrol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Megestrol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Megestrol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Megestrol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Megestrol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Megestrol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Megestrol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Megestrol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Megestrol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Megestrol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Megestrol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Megestrol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Megestrol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Megestrol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Megestrol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Megestrol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Megestrol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Megestrol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Megestrol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Megestrol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Megestrol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Megestrol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Megestrol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Megestrol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Megestrol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Megestrol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Megestrol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Megestrol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Megestrol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Megestrol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Megestrol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Megestrol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Megestrol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Megestrol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Megestrol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Megestrol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Megestrol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Megestrol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Megestrol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Megestrol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Megestrol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Megestrol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Megestrol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Megestrol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Megestrol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Megestrol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Megestrol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Megestrol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Megestrol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Megestrol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Megestrol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Megestrol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Megestrol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Megestrol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Megestrol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Megestrol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Megestrol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Megestrol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Megestrol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Megestrol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Megestrol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Megestrol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Megestrol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Megestrol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Megestrol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Megestrol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Megestrol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Megestrol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Megestrol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Megestrol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Megestrol Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Megestrol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Megestrol Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Megestrol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Megestrol Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Megestrol Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Megestrol Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Megestrol Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Megestrol Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Megestrol Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Megestrol Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Megestrol Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GSK Megestrol Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Mayne Pharma
  44. 8.8.1 Mayne Pharma Company Information
  45. 8.8.2 Mayne Pharma Business Overview
  46. 8.8.3 Mayne Pharma Megestrol Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mayne Pharma Megestrol Product Portfolio
  48. 8.8.5 Mayne Pharma Recent Developments
  49. 8.9 Guccess
  50. 8.9.1 Guccess Company Information
  51. 8.9.2 Guccess Business Overview
  52. 8.9.3 Guccess Megestrol Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guccess Megestrol Product Portfolio
  54. 8.9.5 Guccess Recent Developments
  55. 8.10 Bristol Myers Squibb
  56. 8.10.1 Bristol Myers Squibb Company Information
  57. 8.10.2 Bristol Myers Squibb Business Overview
  58. 8.10.3 Bristol Myers Squibb Megestrol Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bristol Myers Squibb Megestrol Product Portfolio
  60. 8.10.5 Bristol Myers Squibb Recent Developments
  61. 8.11 Abnova
  62. 8.11.1 Abnova Company Information
  63. 8.11.2 Abnova Business Overview
  64. 8.11.3 Abnova Megestrol Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Abnova Megestrol Product Portfolio
  66. 8.11.5 Abnova Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Megestrol Value Chain Analysis
  2. 9.1.1 Megestrol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Megestrol Sales Mode & Process
  6. 9.2 Megestrol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Megestrol Distributors
  9. 9.2.3 Megestrol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst